Risk of New or Recurrent Cancer in Patients With...

American Journal of Gastroenterology 2019 / 10 Vol. 114; Iss. Supplement

Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Vedolizumab or Ustekinumab

Pang, Alice, Hudesman, David P., Chang, Shannon, Axelrad, Jordan E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
114
Journal:
American Journal of Gastroenterology
DOI:
10.14309/01.ajg.0000592124.06417.87
Date:
October, 2019
File:
PDF, 146 KB
2019
Conversion to is in progress
Conversion to is failed